Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

Transient in utero disruption of cystic fibrosis transmembrane conductance regulator causes phenotypic changes in alveolar type II cells in adult rats.

Gad A, Callender DL, Killeen E, Hudak J, Dlugosz MA, Larson JE, Cohen JC, Chander A.

BMC Cell Biol. 2009 Mar 31;10:24. doi: 10.1186/1471-2121-10-24.

2.

Craniofacial resections in the elderly: an outcome study.

Hentschel SJ, Nader R, Suki D, Dastgir A, Callender DL, DeMonte F.

J Neurosurg. 2004 Dec;101(6):935-43.

PMID:
15597754
3.

Sebaceous carcinoma ex-pleomorphic adenoma: a rare phenotypic occurrence.

Cohn ML, Callender DL, El-Naggar AK.

Ann Diagn Pathol. 2004 Aug;8(4):224-6.

PMID:
15290674
4.

Hospitalization of an oncology patient suspected of having severe acute respiratory syndrome: a setup for an infection control quagmire at a comprehensive cancer center.

Safdar A, Chemaly RF, Perego CA, Gonzalez VR, Rolston KV, Raad II, Tarrand JJ, Callender DL.

Cancer. 2003 Dec 15;98(12):2738-9. No abstract available.

5.

Characterization of laryngopharyngeal reflux in patients with premalignant or early carcinomas of the larynx.

Lewin JS, Gillenwater AM, Garrett JD, Bishop-Leone JK, Nguyen DD, Callender DL, Ayers GD, Myers JN.

Cancer. 2003 Feb 15;97(4):1010-4.

6.

Molecular analysis of chromosome 16q regions in dermal analogue tumors of salivary glands: a genetic link to dermal cylindroma?

Choi HR, Batsakis JG, Callender DL, Prieto VG, Luna MA, El-Naggar AK.

Am J Surg Pathol. 2002 Jun;26(6):778-83.

PMID:
12023583
7.

Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma.

Hoang MP, Callender DL, Sola Gallego JJ, Huang Z, Sneige N, Luna MA, Batsakis JG, El-Naggar AK.

Int J Oncol. 2001 Oct;19(4):865-71.

PMID:
11562768
8.

Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responses.

Garden AS, Glisson BS, Ang KK, Morrison WH, Lippman SM, Byers RM, Geara F, Clayman GL, Shin DM, Callender DL, Khuri FR, Goepfert H, Hong WK, Peters LJ.

J Clin Oncol. 1999 Aug;17(8):2390-5.

PMID:
10561301
9.

Antibiotic prophylaxis in head and neck oncologic surgery: the role of gram-negative coverage.

Callender DL.

Int J Antimicrob Agents. 1999 Aug;12 Suppl 1:S21-5; discussion S26-7. Review.

PMID:
10526870
10.

Cytogenetic analysis of a primary salivary gland myoepithelioma.

el-Naggar AK, Lovell M, Callender DL, Ordonez NG, Killary AM.

Cancer Genet Cytogenet. 1999 Aug;113(1):49-53.

PMID:
10459346
11.

Limited nonrandom chromosomal aberrations in a recurrent adenoid cystic carcinoma of the parotid gland.

el-Naggar AK, Lovell M, Callender DL, Killary AM.

Cancer Genet Cytogenet. 1999 Feb;109(1):66-9.

PMID:
9973962
12.

Concurrent cytogenetic, interphase fluorescence in situ hybridization and DNA flow cytometric analyses of a carcinoma ex-pleomorphic adenoma of parotid gland.

el-Naggar AK, Lovell M, Callender DL, Ordonez NG, Killary AM.

Cancer Genet Cytogenet. 1998 Dec;107(2):132-6. Review.

PMID:
9844608
13.

Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.

Shin DM, Glisson BS, Khuri FR, Ginsberg L, Papadimitrakopoulou V, Lee JJ, Lawhorn K, Gillenwater AM, Ang KK, Clayman GL, Callender DL, Hong WK, Lippman SM.

J Clin Oncol. 1998 Apr;16(4):1325-30.

PMID:
9552033
14.

Postoperative radiotherapy for malignant tumors of the parotid gland.

Garden AS, el-Naggar AK, Morrison WH, Callender DL, Ang KK, Peters LJ.

Int J Radiat Oncol Biol Phys. 1997 Jan 1;37(1):79-85.

PMID:
9054880
15.

Changing concepts in the pathogenesis and management of thyroid carcinoma.

Gagel RF, Goepfert H, Callender DL.

CA Cancer J Clin. 1996 Sep-Oct;46(5):261-83. Review.

PMID:
8806393
16.

Juvenile nasopharyngeal angiofibroma: an update of therapeutic management.

Ungkanont K, Byers RM, Weber RS, Callender DL, Wolf PF, Goepfert H.

Head Neck. 1996 Jan-Feb;18(1):60-6.

PMID:
8774923
17.

Elective modified neck dissection for treatment of the clinically negative (N0) neck.

Callender DL, Weber RS.

Cancer Treat Res. 1995;74:221-41. Review. No abstract available.

PMID:
7779618
18.

Differentiated thyroid cancer--papillary and follicular carcinomas.

Goepfert H, Callender DL.

Am J Otolaryngol. 1994 May-Jun;15(3):167-79. Review. No abstract available.

PMID:
8024104
19.

Head and neck cancer. The problem.

Blair EA, Callender DL.

Clin Plast Surg. 1994 Jan;21(1):1-7. Review.

PMID:
8112003
20.

Extracranial, extraspinal meningiomas of the head and neck.

Kershisnik M, Callender DL, Batsakis JG.

Ann Otol Rhinol Laryngol. 1993 Dec;102(12):967-70. Review.

PMID:
8285520
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk